For the quarter ending 2025-09-30, LSTA has $21,759K in assets. $4,640K in debts. $18,998K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 18,998 | 16,835 | ||
| Marketable securities | 0 | 5,135 | ||
| Accounts receivable | 502 | 501 | ||
| Prepaid and other current assets | 2,075 | 2,414 | ||
| Total current assets | 21,575 | 24,885 | ||
| Property and equipment, net | 22 | 48 | ||
| Acquired license - intangible, net | 139 | 157 | ||
| Other assets | 23 | 70 | ||
| Total assets | 21,759 | 25,160 | ||
| Accounts payable | 619 | 782 | ||
| Accrued liabilities | 3,949 | 3,531 | ||
| Total current liabilities | 4,568 | 4,313 | ||
| Other long-term liabilities | 72 | 72 | ||
| Total liabilities | 4,640 | 4,385 | ||
| Common stock, 0.001 par value, authorized 500,000,000 shares issued 8,756,686 and 8,409,582 shares at september 30, 2025 and december 31, 2024, respectively and outstanding, 8,755,948 and 8,408,844 shares at september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 579,812 | 579,227 | ||
| Treasury stock, at cost 738 shares at september 30, 2025 and december 31, 2024 | 708 | 708 | ||
| Accumulated deficit | -561,698 | -557,449 | ||
| Accumulated other comprehensive loss | -42 | -50 | ||
| Total lisata therapeutics, inc. stockholders' equity | 17,373 | 21,029 | ||
| Non-controlling interests | -254 | -254 | ||
| Total equity | 17,119 | 20,775 | ||
| Total liabilities, non-controlling interests and stockholders' equity | 21,759 | 25,160 | ||
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)